These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Satchell SC; Tooke JE Diabetologia; 2008 May; 51(5):714-25. PubMed ID: 18347777 [TBL] [Abstract][Full Text] [Related]
3. Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Swärd P; Rippe B Acta Physiol (Oxf); 2012 Mar; 204(3):294-307. PubMed ID: 21812939 [TBL] [Abstract][Full Text] [Related]
4. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
5. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Naidoo DP Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063 [TBL] [Abstract][Full Text] [Related]
6. Time to abandon microalbuminuria? Ruggenenti P; Remuzzi G Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239 [TBL] [Abstract][Full Text] [Related]
7. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations. Jensen JS Dan Med Bull; 2000 Apr; 47(2):63-78. PubMed ID: 10822799 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of microalbuminuria in the general population. Metcalf PA; Scragg RK J Diabetes Complications; 1994; 8(3):157-63. PubMed ID: 8086651 [TBL] [Abstract][Full Text] [Related]
9. Microalbuminuria: marker or maker of cardiovascular disease. Abdelhafiz AH; Ahmed S; El Nahas M Nephron Exp Nephrol; 2011; 119 Suppl 1():e6-10. PubMed ID: 21832857 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Atkins RC; Polkinghorne KR; Briganti EM; Shaw JE; Zimmet PZ; Chadban SJ Kidney Int Suppl; 2004 Nov; (92):S22-4. PubMed ID: 15485411 [TBL] [Abstract][Full Text] [Related]
12. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes. Nosadini R; Brocco E Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531 [TBL] [Abstract][Full Text] [Related]
13. Albuminuria as a marker of kidney and cardio-cerebral vascular damage. Isle of Youth Study (ISYS), Cuba. Herrera R; Almaguer M; Chipi J; Martínez O; Bacallao J; Rodríguez N; Abreu Mde L; Fariña O; Roche Mdel C MEDICC Rev; 2010 Oct; 12(4):20-6. PubMed ID: 21048540 [TBL] [Abstract][Full Text] [Related]
14. Predictors for the development of microalbuminuria and interaction with renal function. Chatzikyrkou C; Menne J; Izzo J; Viberti G; Rabelink T; Ruilope LM; Rump C; Mertens PR; Haller H J Hypertens; 2017 Dec; 35(12):2501-2509. PubMed ID: 29035939 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. McKenna K; Thompson C Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584 [TBL] [Abstract][Full Text] [Related]
16. New insights into the significance of microalbuminuria. MacIsaac RJ; Jerums G; Cooper ME Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):83-91. PubMed ID: 15090864 [TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Pistrosch F; Herbrig K; Kindel B; Passauer J; Fischer S; Gross P Diabetes; 2005 Jul; 54(7):2206-11. PubMed ID: 15983223 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Konta T; Hao Z; Abiko H; Ishikawa M; Takahashi T; Ikeda A; Ichikawa K; Takasaki S; Kubota I Kidney Int; 2006 Aug; 70(4):751-6. PubMed ID: 16807548 [TBL] [Abstract][Full Text] [Related]
20. The kidney, a cardiovascular risk marker, and a new target for therapy. de Zeeuw D; Hillege HL; de Jong PE Kidney Int Suppl; 2005 Sep; (98):S25-9. PubMed ID: 16108967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]